IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Endra Life Sciences Inc COM New

CUSIP: 29273B104 | 65 institutional holders

Quarters

Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2023

Worth Asset Management, LLC670
0.0% of portfolio›$938
StyleTurnoverLocationFiled
Worth Asset Management, LLC
670$9380.0%ETFHighDallas, TX2023-07-11